SCHEMBL22276161

SCHEMBL22276161

NC(=O)c1cccc2ccn(Cc3cc4ccccc4o3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 1/20 0.43
NPC1 O15118 1/20 0.43
CYP19A1 P11511 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRK1 P41145 1/20 0.41
STING1 Q86WV6 1/20 0.41
HTR2B P41595 2/20 0.40
HTR1A P08908 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
DRD2 P14416 2/20 0.40
DRD4 P21917 2/20 0.40
DRD3 P35462 2/20 0.40
AGXT P21549 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
GALR3 O60755 1/20 0.39
FLT3 P36888 1/20 0.39
DUSP3 P51452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12584456 0.89 STING1 (0.48) NPC1CYP19A1LOXL2STING1HTR2B
SCHEMBL29518204 0.89 STING1 (0.48) NPC1CYP19A1LOXL2STING1HTR2B
SCHEMBL22276172 0.88 ATM (0.38) GPR52STING1HTR2BHTR1AMAOB
SCHEMBL12584451 0.85 KDM4E (0.50) NPC1CYP19A1STING1HTR2BHTR1A
SCHEMBL28484362 0.80 NPC1 (0.38) NPC1CYP19A1STING1HTR2BHTR1A
SCHEMBL22276195 0.79 STING1 (0.44) NPC1CYP19A1LOXL2STING1HTR2B
SCHEMBL29405494 0.79 STING1 (0.44) NPC1CYP19A1LOXL2STING1HTR2B
SCHEMBL22276046 0.78 STING1 (0.48) CYP19A1LOXL2STING1HTR2BHTR1A
SCHEMBL12584914 0.78 HTR2B (0.43) CYP19A1LOXL2STING1HTR2BHTR1A
SCHEMBL988141 0.77 MAOB (0.48) NPC1KDM4EALDH1A1MAOBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3889134-A1 COMPOUND FOR INHIBITING PGE2/EP4 SIGNALING TRANSDUCTION INHIBITING, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF Keythera (Suzhou) Pharmaceuticals Co. Ltd. (CN) 2021-10-06 EP disclosed
WO-2020151566-A1 COMPOUND FOR INHIBITING PGE2/EP4 SIGNALING TRANSDUCTION INHIBITING, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF 凯复制药有限公司 2020-07-30 WO disclosed